The promise of long-term treatment for neovascular age-related macular degeneration

Lancet. 2024 Apr 20;403(10436):1517-1519. doi: 10.1016/S0140-6736(24)00428-8. Epub 2024 Mar 27.

Author

Elizabeth P Rakoczy¹

Affiliation

¹ The University of Western Australia, Centre for Ophthalmology and Visual Science, Crawley, WA 6009, Australia. Electronic address: elizabeth.rakoczy@uwa.edu.au.

PMID: 38554724
DOI: 10.1016/S0140-6736(24)00428-8

No abstract available

Publication types

Comment

MeSH terms

Angiogenesis Inhibitors / therapeutic use
Humans
Macular Degeneration* / drug therapy
Ranibizumab / therapeutic use
Retrospective Studies
Tomography, Optical Coherence
Wet Macular Degeneration* / drug therapy

Substances

Ranibizumab
Angiogenesis Inhibitors